Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,390,020
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
342,140
-
Shares change
-
-53,290
-
Total reported value, excl. options
-
$2,822,000
-
Value change
-
-$4,604,714
-
Number of buys
-
9
-
Number of sells
-
6
-
Price
-
$8.25
Institutional Holders of Arcadia Biosciences, Inc. - Common Stock (RKDA) as of Q2 2018
As of 30 Jun 2018 Arcadia Biosciences, Inc. - Common Stock (RKDA) had 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 342,140 shares of stock of the company.
Largest 10 holders included SABBY MANAGEMENT, LLC, CVI Holdings, LLC, BANK OF MONTREAL /CAN/, ARDSLEY ADVISORY PARTNERS, WELLS FARGO & COMPANY/MN, Advisor Group, Inc., UBS Group AG, DEUTSCHE BANK AG\, SeaCrest Wealth Management, LLC, and Valeo Financial Advisors, LLC.
This table shows 17 institutional shareholders of the security as of 30 Jun 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.